Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control
- 29 October 2001
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 38 (5), 1307-1312
- https://doi.org/10.1016/s0735-1097(01)01555-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Plasminogen-Activator Inhibitor Type 1 and Coronary Artery DiseaseNew England Journal of Medicine, 2000
- A revised model of platelet aggregationJCI Insight, 2000
- Local Inhibition of Tissue Factor Reduces the Thrombogenicity of Disrupted Human Atherosclerotic PlaquesCirculation, 1999
- In Vivo Formation of 8-Iso-Prostaglandin F 2α and Platelet Activation in Diabetes MellitusCirculation, 1999
- Effect of Advanced Glycation End Product–Modified Albumin on Tissue Factor Expression by MonocytesArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Angiographic Findings and Outcome in Diabetic Patients Treated With Thrombolytic Therapy for Acute Myocardial Infarction: The GUSTO-I ExperienceJournal of the American College of Cardiology, 1996
- Long-Term Glycemic Control Relates to Mortality in Type II DiabetesDiabetes Care, 1995
- Hyperglycemie and Microvascular and Macrovascular Disease in DiabetesDiabetes Care, 1995
- Antithrombin III activity, von Willebrand factor antigen and platelet function in young diabetic patients treated with multiple insulin injections versus insulin pump treatmentEuropean Journal of Clinical Investigation, 1989
- Plasma β-Thromboglobulin, Platelet Factor 4, Fibrinopeptide A, and Other Hemostatic Functions During Improved, Short-Term Glycemic Control in Diabetes MellitusDiabetes Care, 1984